Dr. Parker has disclosed that she has received clinical research support from Genentech. Ms. Nardi, Ms. Fitzgerald, and Dr. Carlson are employees of NCCN. The remaining authors have disclosed that they have no financial interests, arrangements, or affiliations with the manufacturers of any products discussed in this article or their competitors.
American Society of Clinical Oncology. The state of cancer care in America, 2015: a report by the American Society of Clinical Oncology. J Oncol Pract2015;11:79–113.
CooperZCraigSVGaynorM. The Price Ain't Right? Hospital Prices and Health Spending on the Privately Insured. NBER Working Paper No. 21815 Issued in December2015. Available at: http://www.nber.org/papers/w21815. Accessed March 1 2016.
CoxCGonzalesSKamalR. Analysis of 2016 Premium Changes in the Affordable Care Act's Health Insurance Marketplaces. Kaiser Family Foundation Web site. Available at: http://kff.org/health-reform/fact-sheet/analysis-of-2016-premium-changes-in-the-affordable-care-acts-health-insurance-marketplaces/. Accessed March 1 2016.
GlickSGandhiN. Surviving and Thriving in the New Commercial Environment. Available at: http://www.americangovernance.com/education/symposia/2015/winter/files/feb15glick-gandhi.pdf. Accessed March 1 2016.
MathewsAWArmourS. Biggest Insurer Threatens to Abandon Health Law. Wall Street Journal. November192015. Available at: http://www.wsj.com/articles/unitedhealth-cuts-guidance-evaluating-its-insurance-exchange-segment-1447933310. Accessed March 1 2016.
MathewsAW. Regulators to Shut Down Health Republic Insurance of New York. Wall Street Journal. September252015. Available at: http://www.wsj.com/articles/regulators-to-shut-down-health-republic-insurance-of-new-york-1443222742. Accessed March 1 2016.
CampanileC. ObamaCare Leaves 250 Cancer Patients in Peril. New York Post. November62015. Available at: http://nypost.com/2015/11/06/obamacare-leaves-250-cancer-patients-in-peril/. Accessed March 1 2016.
Newsroom: Modest Health Benefit Cost Growth Continues as Consumerism Kicks Into High Gear. Mercer Web site. November192014. Available at: http://www.mercer.com/newsroom/modest-health-benefit-cost-growth-continues-as-consumerism-kicks-into-high-gear.html. Accessed March 1 2016.
2015 Employer Health Benefits Survey. The Henry J. Kaiser Family Foundation Web site. September222015. Available at: http://kff.org/report-section/ehbs-2015-summary-of-findings/. Accessed March 1 2016.
Milliman. Milliman Report: High-Value Healthcare Provider Networks. AHIP Web site. July12014. Available at: http://www.ahip.org/MillimanReportHPN2014/. Accessed March 1 2016.
AndrewsM. Warning: Opting Out of Your Insurance Plan's Provider Network is Risky. Kaiser Health News Web site. Available at: http://khn.org/news/michelle-andrews-opting-out-insurer-provider-network-risky/. Accessed March 1 2016.
Avalere Health LLC. Network Design: Trends in Tiered and Narrow Insurance Networks. October2015. Available at: https://www.whathealthcarecostsnj.com/wp-content/uploads/2015/10/Avalere-Whitepaper.pdf. Accessed March 1 2016.
HempsteadK. Burnt Offerings? PPOs DECLINE in Marketplace Plans. Robert Wood Johnson Foundation Web site. Available at: http://www.rwjf.org/en/library/research/2015/10/decline-in-ppo-offerings-in-marketplace-plans-in-2016.html. Accessed March 1 2016.
ApplebyJRauJ. As HMOs Dominate Alternatives Become More Expensive. Kaiser Health News Web site. Available at: http://khn.org/news/as-hmos-dominate-alternatives-become-more-expensive/. Accessed March 1 2016.
PearsonCFChoeSH. Leading Cancer Centers May Be More Widely Included in Exchange Networks Than Expected. Avalere Health Web site. Available at: http://avalere.com/expertise/life-sciences/insights/leading-cancer-centers-may-be-more-widely-included-in-exchange-networks-tha. Accessed March 1 2016.
DiasioR. NCCN Work Group Report on Access to Academic Cancer Centers. Presented at the NCCN Policy Summit: Value, Access, and Cost of Cancer Care Policy Summit; September112015; Washington, DC.
SloanCCarpenterE. Exchange Plans Include 34 Percent Fewer Providers than the Average for Commercial Plans. Avalere Health Web site. Available at: http://avalere.com/expertise/managed-care/insights/exchange-plans-include-34-percent-fewer-providers-than-the-average-for-comm. Accessed March 1 2016.
WolfsonJSunCLKangT. Impact of treatment site in adolescents and young adults with central nervous system tumors. J Natl Cancer Inst2014;106:dju166.
WolfsonJASunCLWyattL. Impact of care at comprehensive cancer centers on outcome: results from a population-based study. Cancer2015;121:3885–3893.
PfisterDGRubinDMElkinEB. Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage. JAMA Oncol2015;1:1303–1310.
LongacreMLCharapESBuzagloJS. Defining value in oncology: perspectives from patients with metastatic breast cancer. cancer support community. Presented at the Association for Value-Based Cancer Care, 5th Annual Conference; May3–62015; Washington, DC.
GersonS. NCCN Work Group Report on Value of Academic Cancer Centers. Presented at the NCCN Policy Summit: Value, Access, and Cost of Cancer Care Policy Summit; September112015; Washington, DC.
GordonTABurleysonGPTielschJM. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg1995;221:43–49.
BowenJMPerryAMLauriniJA. Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care. Br J Haematol2014;166:202–208
AlvarnasJA. Quality value innovation: developing a value proposition for care of patients with hematological malignancies. Presented at the NCCN Cancer Center Directors Meeting; April132015; Duarte, CA.
AlvarnasJMajkowskiGRLevineAM. Moving toward economically sustainable value-based cancer care in the academic setting. JAMA Oncol2015;1:1221–1222.
FitchKPyensinB. Cancer Patients Receiving Chemotherapy: Opportunities for Better Management. Milliman, Inc. Available at: http://www.milliman.com/uploadedFiles/insight/research/health-rr/cancer-patients-receiving-chemotherapy.pdf. Accessed March 1 2016.
BrooksGALiLUnoH. Acute hospital care is the chief driver of regional spending variation in medicare patients with advanced cancer. Health Affairs2014;33:1793–1800.
VBCC. The Big Cost Drivers in End-of-Life Cancer Care Are Not the Drugs. June2011 Volume 2 No 3. Available at: http://www.valuebasedcancer.com/vbcc-issues/2011/june-2011-vol-2-no-3/558-vbcc-558. Accessed June 20 2016.
ZafarYPeppercornJMSchragD. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist2013;18:381–390.
BuzagloJSMillerMFKartenC. Multiple myeloma patient experience with financial toxicity: findings from the Cancer Experience Registry. Presented at the ASH 57th Annual Meeting and Exposition; December5–82015; Orlando, FL.
ParkerB. NCCN Work Group Report on Cost of Cancer Care. Presented at the NCCN Policy Summit: Value, Access, and Cost of Cancer Care Policy Summit; September112015; Washington, DC.